https://news.augustaheadlines.com/story/402977/diabetic-retinopathy-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-01-16T18:22:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/402976/cutaneous-tcell-lymphoma-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-01-16T18:20:15+00:00 daily 1.0 https://news.augustaheadlines.com/story/402975/cutaneous-lupus-erythematosus-clinical-trials-a-drug-pipeline-analysis-report-2022-delveinsight.html 2023-01-16T18:18:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/402974/cystic-fibrosis-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-01-16T18:16:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/402973/dravet-syndrome-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-01-16T18:12:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/402972/adeno-associated-virus-vectors-in-gene-therapy-pipeline-insight-and-clinical-trial-analysis-70-companies-and-235-drugs.html 2023-01-16T18:10:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/402971/vitamin-mineral-premixes-market-size-share-growth-opportunities-industry-analysis-and-forecast-to-2027.html 2023-01-16T18:08:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/402970/acute-myeloid-leukemia-pipeline-insight-and-clinical-trial-analysis-260-companies-and-260-drugs.html 2023-01-16T18:06:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/402969/atopic-dermatitis-pipeline-insight-and-clinical-trial-analysis-100-companies-and-100-drugs.html 2023-01-16T18:04:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/402968/wet-agerelated-macular-degeneration-pipeline-insight-report-and-clinical-trial-analysis-70-companies-and-80-drugs.html 2023-01-16T18:02:02+00:00 daily 1.0